{"nct_id":"NCT03829332","title":"Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7902-007/E7080-G000-314/LEAP-007)","status":"COMPLETED","status_verified_date":"2025-03","start_date":"2019-03-13","start_date_type":"ACTUAL","primary_completion_date":"2021-05-19","primary_completion_date_type":"ACTUAL","completion_date":"2024-04-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}